| 溶解性 | DMSO |
| 存贮条件 | 储存温度-20°C |
| 生化机理 | Radezolid (INN, codenamed RX-1741) is a novel oxazolidinone antibiotic being developed by Rib-X Pharmaceuticals, Inc. for the treatment of serious multi-drug–resistant infections. Radezolid has completed two phase-II clinical trials. One of these clinical trials was for uncomplicated skin and skin-structure infections (uSSSI) and the other clinical trial was for community acquired pneumonia (CAP). From Wikipedia |
| 别名 | ; |
Radezolid,噁唑烷酮类抗生素
Radezolid （订货以英文为准）
编号：R126228
CAS号：869884-78-6
分子式：C22H23FN6O3
分子量：438.45
| 产品名称 | Radezolid |
| 中文名称 | Radezolid,噁唑烷酮类抗生素 |
| CAS号 | 869884-78-6 |
| 分子式（M.F.） | C22H23FN6O3 |
| 分子量（M.W.） | 438.45 |
| 储存条件 | -20°C储存 |
| 标识符号 | https://www.aladdin-e.com/images/ghs/ghs06.jpg |
| 信号词 | Danger |
| 危害声明 | H300 |
| 警示性声明 | P264-P301 + P310 |
| RTECS | XJ9095000 |
| WGK德国 | 3 |
搜索质检报告(COA)
搜索MSDS
相关产品
党沛 
